{"id":78283,"date":"2022-11-13T11:58:35","date_gmt":"2022-11-13T11:58:35","guid":{"rendered":"https:\/\/irise.com.ge\/new\/?post_type=partner&#038;p=78283"},"modified":"2022-11-13T11:58:35","modified_gmt":"2022-11-13T11:58:35","slug":"lionex","status":"publish","type":"partner","link":"https:\/\/irise.com.ge\/en\/partner\/lionex\/","title":{"rendered":"LIONEX"},"template":"","meta":[],"partner_category":[289],"class_list":["post-78283","partner","type-partner","status-publish","hentry","partner_category-clinical-diagnostics","partner_category-289","description-off"],"acf":{"partner_description":"<strong>LIONEX \u00a0is a German biotech company active in the fields of biomedicine and human health with special emphasis on TUBERCULOSIS (TB). Our focus is on research and In-Vitro-Diagnostic (IVD) product development for infectious diseases and cancer. LIONEX has recently launched a new IGRA (Interferon Gamma Release Assay) diagnostic test \u00a0called LIOFeron\u00aeTB\/LTBI\u00a0for LTBI (Latent Tuberculosis Infection).<\/strong>","partner_url":"https:\/\/lionex.de\/","logo":78284,"featured_image":78286},"_links":{"self":[{"href":"https:\/\/irise.com.ge\/en\/wp-json\/wp\/v2\/partner\/78283","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/irise.com.ge\/en\/wp-json\/wp\/v2\/partner"}],"about":[{"href":"https:\/\/irise.com.ge\/en\/wp-json\/wp\/v2\/types\/partner"}],"wp:attachment":[{"href":"https:\/\/irise.com.ge\/en\/wp-json\/wp\/v2\/media?parent=78283"}],"wp:term":[{"taxonomy":"partner_category","embeddable":true,"href":"https:\/\/irise.com.ge\/en\/wp-json\/wp\/v2\/partner_category?post=78283"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}